The Einstein Nathan Shock Center (E-NSC) has grown to includes internal (46) and external (33) members who are engaged in meaningful collaborations and programs and are recipients of P&F support. This growth was accompanied by an impressive publication record E-NSC members as exemplified in 124 papers and reviews in Nature, Cell and Science journals, a staggering average of approximately five collaborative papers (with other E-NSC members) per E-NSC investigator and the proactive recruitment and ?conversion? of many members to the E-NSC who were not members for previous submissions. Other resources are also important for E-NSC success, including large aging programs (P01 and U grants), an ongoing NIH-funded Einstein Aging (T32) training grant, a complementary graduate course on the Biology of Aging, and resources from funded projects through the Einstein Glenn Center for Biology of Human Aging. Activities of the E-NSC were leveraged by supplemental Institutional funding; the Center awarded 26 pilot and feasibility grants, with good outcomes. The three Research Resource Cores provided services to 167 investigators, offering state-of the art services with dependable quality control at an affordable price. The (abridged) aims of the E-NSC are:
Aim 1) To enhance and expand ongoing biology of aging research by providing access to cutting-edge technology and innovative approaches through services that (excluding health span of rodents) do not exist in other NSCs: a) The Proteostasis of Aging Core (PAC) (Cuervo) will continue to provide assays, reagents and expertise for the analysis of proteostasis in aging. The PAC Innovation Unit will continue developing and implementing methodologies for the study of human aging proteostasis. It now includes a drug development consulting service. b) The Health Span Core (HSC) (Huffman) will continue to provide sophisticated integrative studies for determination of healthy aging physiology and resources for parabiosis studies. c) The Human Multi-omics Core (HMOC) (Vijg) will add services for planning and executing single cell epi/genomics analyses to address important problems in biology of aging. It will provide omic data (whole exome sequencing, aftamer proteomic data, transcriptomic and metabolomic) from well phenotyped human aging data.
Aim 2) To plan and coordinate geroscience activities, foster collaborations and integrate activities of the Research Cores and research efforts at Einstein and other institutions. The Administrative Core (Barzilai/Cuervo) will continue implementing and promoting enrichment activities through seminars, mini-retreats and NSC national meetings, and developing resources to facilitate integration of groups engaged in aging research at institutions with limited aging research support; the Core also ensure that E-NSC services are well publicized.
Aim 3) To provide support and an environment conducive to promotion of thriving new investigators in biology of aging through a Research Development Core (Milman/Singh). We will provide P&F awards and mentoring to new aging researchers and support for expansion/divergence of other ongoing exciting research programs.

Public Health Relevance

The Einstein-Nathan Shock Center of Excellence is part of the biggest Institute in the world for the study of the biology of aging , encompassing approximately 80 labs, which have emerged to stimulate the investigator intellectual environment for specific fields of research and to provide technology that is not practicable for the individual scientist. With support for three research resource cores, pilot & feasibility awards, a designated mentor system, program enrichment and a yearly mini-retreat, this Einstein-Nathan Shock Center will continue to transform the field with the goal to delay human aging and its associated diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
2P30AG038072-13
Application #
10045030
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Kerr, Candace L
Project Start
2010-08-15
Project End
2025-05-31
Budget Start
2020-09-15
Budget End
2021-05-31
Support Year
13
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
081266487
City
Bronx
State
NY
Country
United States
Zip Code
10461
Guan, Fangxia; Tabrizian, Tahmineh; Novaj, Ardijana et al. (2018) Dietary Walnuts Protect Against Obesity-Driven Intestinal Stem Cell Decline and Tumorigenesis. Front Nutr 5:37
Tekirdag, Kumsal; Cuervo, Ana Maria (2018) Chaperone-mediated autophagy and endosomal microautophagy: Joint by a chaperone. J Biol Chem 293:5414-5424
Theofilas, Panos; Ehrenberg, Alexander J; Nguy, Austin et al. (2018) Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans. Neurobiol Aging 61:1-12
Choi, Jiahn; Rakhilin, Nikolai; Gadamsetty, Poornima et al. (2018) Intestinal crypts recover rapidly from focal damage with coordinated motion of stem cells that is impaired by aging. Sci Rep 8:10989
Sathyan, Sanish; Barzilai, Nir; Atzmon, Gil et al. (2018) Genetic Insights Into Frailty: Association of 9p21-23 Locus With Frailty. Front Med (Lausanne) 5:105
Amengual, Jaume; Guo, Liang; Strong, Alanna et al. (2018) Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100. Circ Res 122:568-582
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Bejarano, Eloy; Murray, John W; Wang, Xintao et al. (2018) Defective recruitment of motor proteins to autophagic compartments contributes to autophagic failure in aging. Aging Cell :e12777
Gong, Zhenwei; Tasset, Inmaculada; Diaz, Antonio et al. (2018) Humanin is an endogenous activator of chaperone-mediated autophagy. J Cell Biol 217:635-647
Hui, Ken Y; Fernandez-Hernandez, Heriberto; Hu, Jianzhong et al. (2018) Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. Sci Transl Med 10:

Showing the most recent 10 out of 129 publications